Article info

Download PDFPDF

Original article
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C

Authors

  1. Correspondence to Professor Massimo Colombo, 1st Division of Gastroenterology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Via F. Sforza 35, Milan 20122, Italy; massimo.colombo{at}unimi.it
View Full Text

Citation

Colombo M, Fernández I, Abdurakhmanov D, et al
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C

Publication history

  • Received July 15, 2013
  • Revised October 3, 2013
  • Accepted October 15, 2013
  • First published November 7, 2013.
Online issue publication 
June 06, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.